Boston Scientific (BSX)

NYSE Health Care Health Care Equipment S&P 500

$42.75

-1.89 (-4.23%)

Close of Nov 06, 2026 · end-of-day data

Source: Boston Scientific's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 03, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$8.39B	$9.05B	$9.82B	$10.73B	$9.91B	$11.89B	$12.68B	$14.24B	$16.75B	$20.07B
Cost of revenue	$2.42B	$2.59B	$2.81B	$3.12B	$3.46B	$3.71B	$3.96B	$4.34B	$5.26B	$6.22B
Gross profit	$5.96B	$6.46B	$7.01B	$7.62B	$6.45B	$8.18B	$8.73B	$9.90B	$11.49B	$13.85B
Research & development	$920.00M	$997.00M	$1.11B	$1.17B	$1.14B	$1.20B	$1.32B	$1.41B	$1.61B	$2.05B
Selling, general & admin	$3.10B	$3.29B	$3.57B	$3.94B	$3.79B	$4.36B	$4.52B	$5.19B	$5.98B	$6.89B
Operating income	$447.00M	$1.28B	$1.51B	$1.52B	-$80.00M	$1.20B	$1.65B	$2.34B	$2.60B	$3.61B
Interest expense	$233.00M	$229.00M	$241.00M	$473.00M	$361.00M	$341.00M	$470.00M	$265.00M	$305.00M	$349.00M
Pre-tax income	$177.00M	$933.00M	$1.42B	$687.00M	-$79.00M	$1.08B	$1.14B	$1.99B	$2.28B	$3.38B
Income tax	-$170.00M	$828.00M	-$249.00M	-$4.01B	$2.00M	$36.00M	$443.00M	$393.00M	$436.00M	$493.00M
Net income	$347.00M	$104.00M	$1.67B	$4.70B	-$115.00M	$985.00M	$642.00M	$1.57B	$1.85B	$2.90B
EBITDA	$1.26B	$2.13B	$2.40B	$2.53B	$1.04B	$2.29B	$2.79B	$3.54B	$3.87B	$4.98B
EPS (basic)	$0.26	$0.08	$1.21	$3.38	$-0.08	$0.69	$0.45	$1.08	$1.26	$1.96
EPS (diluted)	$0.25	$0.08	$1.19	$3.33	$-0.08	$0.69	$0.45	$1.07	$1.25	$1.94
Diluted shares	1.38B	1.39B	1.40B	1.41B	1.42B	1.43B	1.44B	1.46B	1.49B	1.49B
Gross margin	71.1%	71.3%	71.4%	71.0%	65.0%	68.8%	68.8%	69.5%	68.6%	69.0%
Operating margin	5.3%	14.2%	15.3%	14.1%	-0.8%	10.1%	13.0%	16.5%	15.5%	18.0%
Net margin	4.1%	1.1%	17.0%	43.8%	-1.2%	8.3%	5.1%	11.0%	11.1%	14.4%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$196.00M	$188.00M	$146.00M	$217.00M	$1.73B	$1.93B	$928.00M	$865.00M	$414.00M	$1.97B
Inventory	$955.00M	$1.08B	$1.17B	$1.58B	$1.35B	$1.61B	$1.87B	$2.48B	$2.81B	$2.94B
Total current assets	$3.24B	$3.82B	$4.00B	$4.70B	$6.69B	$6.32B	$5.76B	$6.51B	$6.92B	$8.79B
Goodwill	$6.68B	$7.00B	$7.91B	$10.18B	$9.95B	$11.99B	$12.92B	$14.39B	$17.09B	$18.28B
Total assets	$18.10B	$19.04B	$21.00B	$30.57B	$30.78B	$32.23B	$32.47B	$35.14B	$39.40B	$43.67B
Total current liabilities	$3.59B	$5.65B	$5.26B	$4.87B	$3.68B	$4.27B	$3.80B	$4.93B	$6.40B	$5.44B
Short-term debt	$64.00M	$1.80B	$2.25B	$1.42B	$13.00M	$261.00M	$20.00M	$531.00M	$1.78B	$299.00M
Long-term debt	$5.42B	$3.81B	$4.80B	$8.59B	$9.13B	$8.80B	$8.91B	$8.57B	$8.97B	$11.14B
Total debt	$5.48B	$5.62B	$7.06B	$10.01B	$9.14B	$9.06B	$8.94B	$9.10B	$10.75B	$11.44B
Total liabilities	$11.36B	$12.03B	$12.27B	$16.69B	$15.45B	$15.61B	$14.90B	$15.85B	$17.62B	$19.44B
Shareholders' equity	$6.73B	$7.01B	$8.73B	$13.88B	$15.33B	$16.62B	$17.57B	$19.28B	$21.77B	$24.23B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$1.18B	$1.43B	$310.00M	$1.84B	$1.51B	$1.87B	$1.53B	$2.50B	$3.44B	$4.53B
Capital expenditures	$376.00M	$319.00M	$316.00M	$461.00M	$376.00M	$554.00M	$588.00M	$711.00M	$790.00M	$876.00M
Free cash flow	$806.00M	$1.11B	-$6.00M	$1.38B	$1.13B	$1.32B	$938.00M	$1.79B	$2.65B	$3.66B
Investing cash flow	-$887.00M	-$1.01B	-$1.92B	-$5.04B	-$411.00M	-$1.60B	-$2.01B	-$2.57B	-$5.69B	-$2.64B
Financing cash flow	-$206.00M	$110.00M	$1.43B	$2.97B	$293.00M	-$95.00M	-$548.00M	$5.00M	$1.81B	-$395.00M
Dividends paid	—	—	$0	$0	$28.00M	$55.00M	$55.00M	$28.00M	$0	—
Share buybacks	$0	—	$0	$0	$535.00M	$0	$0	—	—	—
Stock-based compensation	$116.00M	$127.00M	$140.00M	$157.00M	$170.00M	$194.00M	$220.00M	$233.00M	$266.00M	$299.00M
Depreciation & amortization	$815.00M	$844.00M	$894.00M	$1.01B	$1.12B	$1.09B	$1.14B	$1.20B	$1.27B	$1.37B

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$3.73B	$3.86B	$4.12B	$4.21B	$4.56B	$4.66B	$5.06B	$5.07B	$5.29B	$5.20B	$5.44B	$5.14B
Cost of revenue	$1.15B	$1.21B	$1.27B	$1.31B	$1.47B	$1.45B	$1.64B	$1.52B	$1.61B	$1.59B	$1.59B	$1.71B
Gross profit	$2.58B	$2.65B	$2.85B	$2.90B	$3.10B	$3.21B	$3.42B	$3.54B	$3.68B	$3.61B	$3.85B	$3.43B
Research & development	$363.00M	$366.00M	$383.00M	$407.00M	$459.00M	$443.00M	$526.00M	$514.00M	$569.00M	$516.00M	$554.00M	$520.00M
Selling, general & admin	$1.38B	$1.36B	$1.45B	$1.56B	$1.61B	$1.60B	$1.72B	$1.74B	$1.83B	$1.78B	$1.80B	$1.68B
Operating income	$584.00M	$675.00M	$520.00M	$733.00M	$675.00M	$921.00M	$819.00M	$1.05B	$825.00M	$1.10B	$1.18B	$828.00M
Interest expense	$65.00M	$69.00M	$77.00M	$79.00M	$80.00M	$82.00M	$90.00M	$87.00M	$90.00M	$90.00M	$96.00M	$100.00M
Pre-tax income	$505.00M	$608.00M	$420.00M	$669.00M	$585.00M	$805.00M	$941.00M	$939.00M	$700.00M	$1.16B	$1.06B	$733.00M
Income tax	$1.00M	$115.00M	$98.00M	$200.00M	$23.00M	$133.00M	$146.00M	$183.00M	$30.00M	-$176.00M	$155.00M	$153.00M
Net income	$505.00M	$495.00M	$324.00M	$469.00M	$565.00M	$674.00M	$797.00M	$755.00M	$672.00M	$1.34B	$907.00M	$582.00M
EBITDA	$897.00M	$979.00M	$831.00M	$1.04B	$1.02B	$1.25B	$1.16B	$1.39B	$1.19B	$1.45B	$1.53B	$1.19B
EPS (basic)	$0.34	$0.34	$0.22	$0.32	$0.38	$0.46	$0.54	$0.51	$0.46	$0.90	$0.62	$0.40
EPS (diluted)	$0.34	$0.33	$0.22	$0.32	$0.38	$0.45	$0.53	$0.51	$0.45	$0.90	$0.61	$0.40
Diluted shares	4.40M	1.48B	1.48B	1.49B	1.40M	1.49B	1.49B	1.50B	500.00K	1.50B	1.47B	1.45B
Gross margin	69.2%	68.7%	69.2%	68.8%	67.9%	68.8%	67.7%	69.9%	69.6%	69.5%	70.7%	66.7%
Operating margin	15.7%	17.5%	12.6%	17.4%	14.8%	19.8%	16.2%	20.7%	15.6%	21.2%	21.6%	16.1%
Net margin	13.6%	12.8%	7.9%	11.1%	12.4%	14.5%	15.7%	14.9%	12.7%	25.8%	16.7%	11.3%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$865.00M	$2.33B	$2.91B	$2.50B	$414.00M	$725.00M	$534.00M	$1.27B	$1.97B	$1.45B	$539.00M	$609.00M
Inventory	$2.48B	$2.56B	$2.61B	$2.75B	$2.81B	$2.87B	$2.86B	$2.92B	$2.94B	$3.12B	$3.23B	$3.32B
Total current assets	$6.51B	$8.19B	$8.99B	$8.76B	$6.92B	$7.33B	$7.12B	$8.04B	$8.79B	$8.68B	$7.97B	$8.16B
Goodwill	$14.39B	$14.36B	$14.40B	$15.03B	$17.09B	$17.34B	$18.08B	$18.21B	$18.28B	$18.54B	$18.64B	$18.74B
Total assets	$35.14B	$36.67B	$37.11B	$38.08B	$39.40B	$40.14B	$41.56B	$42.71B	$43.67B	$44.35B	$45.22B	$45.46B
Total current liabilities	$4.93B	$4.92B	$5.58B	$5.91B	$6.40B	$5.06B	$5.19B	$5.33B	$5.44B	$4.57B	$6.43B	$5.98B
Short-term debt	$531.00M	$1.08B	$1.58B	$1.65B	$1.78B	$777.00M	$480.00M	$483.00M	$299.00M	$41.00M	$1.71B	$1.04B
Long-term debt	$8.57B	$9.53B	$8.99B	$9.23B	$8.97B	$10.53B	$11.11B	$11.12B	$11.14B	$10.99B	$10.91B	$10.91B
Total debt	$9.10B	$10.62B	$10.57B	$10.88B	$10.75B	$11.31B	$11.59B	$11.60B	$11.44B	$11.03B	$12.62B	$11.95B
Total liabilities	$15.85B	$16.74B	$16.74B	$17.37B	$17.62B	$17.93B	$19.14B	$19.31B	$19.44B	$18.49B	$20.29B	$19.83B
Shareholders' equity	$19.28B	$19.93B	$20.37B	$20.71B	$21.77B	$22.21B	$22.42B	$23.39B	$24.23B	$25.86B	$24.93B	$25.63B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$957.00M	$164.00M	$813.00M	$1.00B	$1.46B	$541.00M	$1.29B	$1.34B	$1.36B	$348.00M	$1.47B	$1.05B
Capital expenditures	$267.00M	$179.00M	$155.00M	$179.00M	$277.00M	$187.00M	$157.00M	$181.00M	$351.00M	$177.00M	$195.00M	$180.00M
Free cash flow	$690.00M	-$15.00M	$658.00M	$823.00M	$1.18B	$354.00M	$1.13B	$1.16B	$1.01B	$171.00M	$1.28B	$868.00M
Investing cash flow	-$1.05B	-$285.00M	-$271.00M	-$1.43B	-$3.70B	-$500.00M	-$1.13B	-$502.00M	-$512.00M	-$591.00M	-$1.96B	-$437.00M
Financing cash flow	$15.00M	$1.57B	$24.00M	$7.00M	$214.00M	$233.00M	-$340.00M	-$104.00M	-$184.00M	-$260.00M	-$410.00M	-$569.00M
Dividends paid	$0	$0	$0	$0	$0	—	—	—	—	—	—	—
Share buybacks	—	—	—	—	—	—	—	$0	—	—	—	$0
Stock-based compensation	$59.00M	$63.00M	$66.00M	$68.00M	$69.00M	$74.00M	$75.00M	$79.00M	$71.00M	$83.00M	$87.00M	$72.00M
Depreciation & amortization	$313.00M	$304.00M	$311.00M	$306.00M	$348.00M	$325.00M	$336.00M	$342.00M	$365.00M	$351.00M	$355.00M	$361.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.